Combined intravenous and topical tranexamic acid versus intravenous use alone in primary total knee and hip arthroplasty: A meta-analysis of randomized controlled trials

International Journal of Surgery

Volumn 36, Issue , 2016, Pages 324-329

  Shang, Jie ^a   Wang, Haibo ^a   Zheng, Bai ^a   Rui, Min ^a   Wang, Yehua ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Combined use; Meta analysis; Total hip arthroplasty; Total knee arthroplasty; Tranexamic acid

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

BLOOD TRANSFUSION; CLINICAL EVALUATION; COCHRANE LIBRARY; DRUG EFFICACY; DRUG SAFETY; EMBASE; HIP ARTHROPLASTY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MEDLINE; META ANALYSIS; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; TOTAL KNEE ARTHROPLASTY; BLOOD LOSS, SURGICAL; HIP REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; KNEE REPLACEMENT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; HUMANS; INJECTIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANEXAMIC ACID;

EID: 84995973185     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2016.11.033     Document Type: Review

References (26)

1. [1] Voorn, V.M., Marang-van de Mheen, P.J., So-Osman, C., Vlieland, T.P., Koopman-van Gemert, A.W., Nelissen, R.G., et al. Designing a strategy to implement cost-effective blood transfusion management in elective hip and knee arthroplasties: a study protocol. Implement Sci., 7, 2012, 58 PMID: 22747693.
2. [2] Gibon, E., Courpied, J.P., Hamadouche, M., Total joint replacement and blood loss: what is the best equation?. Int. Orthop. 37:4 (2013), 735–739 PMID: 23385607.
3. [3] Goodnough, L., Shander, A., Risk and complications of blood transfusions: optimizing outcomes for patients with chemotherapy-induced anemia. John Hopkins Adv. Stud. Med. 8:10 (2008), 357–362.
4. [4] Hoylaerts, M., Lijnen, H.R., Collen, D., Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim. Biophys. Acta 673:1 (1981), 75–85.
5. [5] Wind, T.C., Barfield, W.R., Moskal, J.T., The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J. Arthroplast. 28:7 (2013), 1080–1083 PMID: 23541868.
6. [6] Zhou, X.D., Tao, L.J., Li, J., Wu, L.D., Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch. Orthop. Trauma Surg. 133:7 (2013), 1017–1027 PMID: 23615973.
7. [7] Yue, C., Kang, P., Yang, P., Xie, J., Pei, F., Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J. Arthroplast. 29:12 (2014), 2452–2456 PMID: 24793893.
8. [8] Gomez-Barrena, E., Ortega-Andreu, M., Padilla-Eguiluz, N.G., Pérez-Chrzanowska, H., Figueredo-Zalve, R., Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J. Bone Jt. Surg. Am. 96:23 (2014), 1937–1944 PMID: 25471907.
9. [9] Machin, J.T., Batta, V., Soler, J.A., Sivagaganam, K., Kalairajah, Y., Comparison of intra-operative regimes of tranexamic acid administration in primary total hip replacement. Acta Orthop. Belg. 80:2 (2014), 228–233 PMID: 25090797.
10. [10] Wu, Y.G., Zeng, Y., Yang, T.M., Si, H.B., Cao, F., Shen, B., The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: a randomized, controlled trial. J. Arthroplast., 2016 Apr 12, 10.1016/j.arth.2016.03.059 pii: S0883–5403(16)30041-9.
11. [11] Huang, Z., Ma, J., Shen, B., Pei, F., Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J. Arthroplast. 29:12 (2014), 2342–2346 PMID: 25007725.
12. [12] Jain, N.P., Nisthane, P.P., Shah, N.A., Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? a randomized controlled trial. J. Arthroplast. 31:2 (2016), 542–547 PMID: 26507526.
13. [13] Nielsen, C.S., Jans, O., Orsnes, T., Foss, N.B., Troelsen, A., Husted, H., Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J. Bone Jt. Surg. Am. 98:10 (2016), 835–841 PMID: 27194493.
14. [14] Xie, J., Ma, J., Yue, C., Kang, P., Pei, F., Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: a randomised clinical trial. Hip Int. 26:1 (2016), 36–42, 10.5301/hipint.5000291 PMID: 26391263.
15. [15] Yi, Z., Bin, S., Jing, Y., Zongke, Z., Pengde, K., Tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J. Bone Jt. Surg. Am. 98:12 (2016), 983–991, 10.2106/JBJS.15.00638 PMID: 27307358.
16. [16] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol. 62 (2009), 1006–1012.
17. [17] Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration Web site. www.cochrane-handbook.org. Updated March 2011. Accessed April 2, 2012.
18. [18] Wang, H., Shen, B., Zeng, Y., Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 21:6 (2014), 987–993, 10.1016/j.knee.2014.09.010 PMID: 25450009.
19. [19] Sizer, S.C., Cherian, J.J., Elmallah, R.D., Pierce, T.P., Beaver, W.B., Mont, M.A., Predicting blood loss in total knee and hip arthroplasty. Orthop. Clin. North Am. 46:4 (2015), 445–459 PMID: 26410634.
20. [20] Dalury, D.F., Commentary on an article by Jean Wong, MD, FRCPC, et al.: “Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial”. J. Bone Jt. Surg. Am., 92(15), 2010, e25 PMID: 21048167.
21. [21] Hogan, C.A., Golightly, L.K., Phong, S., Dayton, M.R., Lyda, C., Barber, G.R., Perioperative blood loss in total hip and knee arthroplasty: outcomes associated with intravenous tranexamic acid use in an academic medical center. SAGE Open Med., 4, 2016 Mar 8, 10.1177/2050312116637024 2050312116637024.
22. [22] Maniar, R.N., Kumar, G., Singhi, T., Nayak, R.M., Maniar, P.R., Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin. Orthop. Relat. Res. 470:9 (2012), 2605–2612 PMID: 22419350.
23. [23] Sarzaeem, M.M., Razi, M., Kazemian, G., Moghaddam, M.E., Rasi, A.M., Karimi, M., Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. J. Arthroplast. 29:8 (2014), 1521–1524 PMID: 24726174.
24. [24] Aguilera, X., Martínez-Zapata, M.J., Hinarejos, P., Jordán, M., Leal, J., González, J.C., et al. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch. Orthop. Trauma Surg. 135:7 (2015), 1017–1025 PMID: 25944156.
25. [25] Shemshaki, H., Nourian, S.M., Nourian, N., Dehghani, M., Mokhtari, M., Mazoochian, F., One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch. Orthop. Trauma Surg. 135:4 (2015), 573–588 PMID: 25739992.
26. [26] Kim, T.K., Chang, C.B., Koh, I.J., Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic review. Knee Surg. Sports Traumatol. Arthrosc. 22:8 (2014), 1849–1858 PMID: 23542923.